Immunovant Inc

NASDAQ:IMVT

16.16

-0.64 (-3.81%)

7:15:37 PM EDT: $16.23 +0.07 (+0.43%)

Immunovant Inc Stock, NASDAQ:IMVT

320 West 37th Street, 6th floor, New York, New York 10018

United States of America

Phone: +1.917.580.3099

Number of Employees: 207

http://www.immunovant.com

Description

Immunovant, Inc. is a clinical-stage biopharmaceutical company, which focuses on enabling normal lives for patients with autoimmune diseases. It is developing a novel, fully human monoclonal antibody IMVT-1401 that selectively binds to and inhibits the neonatal fragment crystallizable receptor. The company was founded in 2018 and is headquartered in New York, NY.